It's important to remember constantly that the purpose of carotid interventions, whether it's an endarterectomy (CEA) or stent (CAS), is to prevent future ipsilateral hemispheric neurological events. Our debaters appear to be in agreement on several issues, namely that although early interventions following neurological events may pose a higher risk of complications, they prevent more events than delayed procedures. As Professor Naylor points out, a recently symptomatic carotid stenosis is often thrombus lined and may result in a higher risk of further symptoms in the short term, and when manipulated by surgical intervention or stenting, compared with a more mature lesion. Until now, CEA has been proposed as the optimal early intervention following symptoms to prevent further events; however, is there new information that might offer CAS as an alternative? Our debaters review the literature and their own experience in exploring this. In general, both agree that there is currently insufficient evidence to support CAS as an equivalent therapy in the hyperacute period following symptoms.
Except for the occasional exception, such as the report from the SwedVasc Registry, 1 procedural risks following CEA in the early postsymptom period are quite low and acceptable. However, procedural risks following CAS in the early postsymptom period are much higher, except for the rare exception. 2 So it appears that surgical manipulation (CEA) of a recently symptomatic carotid stenosis, with its thrombus lining and intraplaque haemorrhage, continues to have less procedural risk than the manipulations required with CAS. Future technological advances may change this, but CEA is the preferred therapy at this point.
